The prevalence of EGFR and KRAS mutations detected in the present study is only 9.7%, lower than the one detected in our previous study (21.3%) and in those studies on endometriosis (26%) and arteriovenous malformations of the brain (48%). This evidence concerns the gene EGFR and arteriovenous malformations of the brain.